From June 24 to 26, the 23rd World Pharmaceutical Ingredients China Exhibition (CPHI China 2025) was grandly held at the Shanghai New International Expo Center. Xu Hua, Vice President of the Pharmaceutical Group, Secretary of the Party Committee and Chairman of Jinyao Pharmaceutical, and Li Shuxiang, Deputy Secretary of the Party Committee and General Manager of Jinyao Pharmaceutical, led the team to participate in the exhibition, comprehensively demonstrating the company’s overall strength.

At this exhibition, Jinyao Pharmaceutical carefully arranged three major exhibition areas. Leveraging its profound experience in API exports, the API Export Sales Division (Tianfa Company) of the API Sales Center has maintained its leading position in China’s corticosteroid API exports. The Formulation Export Sales Division (Xinzhuo Company) of the API Sales Center set up its first exclusive booth, focusing on the formulation products of Jinyao Heping and Jinyao Yongguang, laying a solid foundation for the company’s future expansion of formulation exports. Hubei Jinyao continued to strengthen its efforts, forming differentiated advantages based on its distinctive product portfolio.

During the exhibition, more than 400 new and existing customers from various countries and regions around the world visited the booths. They conducted in-depth exchanges with the Jinyao Pharmaceutical team on product layout, technological innovation, market cooperation and other topics, fully demonstrating Jinyao Pharmaceutical’s strong competitiveness in the international pharmaceutical market and injecting new momentum into the company’s deepening of global cooperation and high-quality business development. In line with the company’s development strategy, the three business segments featured precise positioning and clear division of responsibilities. The API Sales Department fully demonstrated the company’s international standing and brand influence in APIs; the Formulation Sales Department discussed the internationalization path of formulations with many partners, focusing on targeted efforts under the “Belt and Road” initiative; Hubei Jinyao conducted in-depth communication with domestic and foreign customers to clarify the international positioning of its injectable products and began to layout its plans for the “15th Five-Year Plan” period.

Through this exhibition, all participants gained a clear understanding of the company’s international strategic layout, strengthened confidence in export sales, and demonstrated their determination to contribute to the company’s export sales targets under the “15th Five-Year Plan”.

Article by: API Sales Center of Jinyao Pharmaceutical